Literature DB >> 1974412

Leucopenia after gold and sulphasalazine treatment.

K L Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1974412      PMCID： PMC1004117          DOI： 10.1136/ard.49.6.422-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.

Authors:  H Bliddal; B Eiberg; P Helin; A Svejgaard
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

2.  HLA-B27, antinuclear antibodies and drug-induced agranulocytosis.

Authors:  K L Schmidt; C Mueller-Eckhardt; H Breithaupt
Journal:  Klin Wochenschr       Date:  1978-12-01

3.  Levamisole-induced adverse reactions in HLA B27-positive rheumatoid arthritis.

Authors:  E M Veys; H Mielants; G Verbruggen
Journal:  Lancet       Date:  1978-01-21       Impact factor: 79.321

4.  Agranulocytosis, levamisole, and HLA-B27.

Authors:  K L Schmidt; C Mueller-Eckhardt
Journal:  Lancet       Date:  1977-07-09       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.